Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q1 2025 · 10-Q
Revenue$37.91M$37.91M−0.1% vs Q1 2024 Net Income-$5.51M-$5.51MN/M vs Q1 2024 EPS Diluted-$0.01-$0.01— vs Q1 2024 Gross Profit$15,089,000−8.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Operating Cash Flow$1,293,000−59.7% Free Cash Flowderived$1,027,000N/M Margins · derivedGross margin39.8%−3.6 pt vs Q1 2024
Operating margin-2.4%−7.7 pt vs Q1 2024
Net margin-14.5%−11.1 pt vs Q1 2024
ended Mar 31, 2025 · filed May 8, 2025 · 38 d after period end